CJC-1295 without DAC is a synthetic growth hormone–releasing hormone (GHRH) analog studied for its ability to stimulate endogenous growth hormone secretion. Unlike the DAC variant, it has a shorter half-life, making it suitable for research requiring controlled, transient GH release. In experimental studies, CJC-1295 without DAC has been investigated for its effects on metabolism, tissue repair, and anabolic pathways. It is commonly considered in preclinical models exploring growth hormone regulation, body composition, and regenerative research. Studied for stimulation of endogenous growth hormone secretion Investigated for effects on metabolism and energy regulation Explored for influence on tissue repair and anabolic pathways Considered in preclinical models of growth, recovery, and endocrine research
